MRSA5B Stock Overview
A logistics operator that manages a railway network in Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
MRS Logística S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$28.00 |
| 52 Week High | R$31.00 |
| 52 Week Low | R$22.06 |
| Beta | 1.58 |
| 11 Month Change | -3.45% |
| 3 Month Change | -1.75% |
| 1 Year Change | 11.73% |
| 33 Year Change | n/a |
| 5 Year Change | 179.72% |
| Change since IPO | 24.44% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MRSA5B | BR Transportation | BR Market | |
|---|---|---|---|
| 7D | -3.4% | -2.3% | -0.1% |
| 1Y | 11.7% | -16.9% | 10.4% |
Return vs Industry: MRSA5B exceeded the BR Transportation industry which returned -21.6% over the past year.
Return vs Market: MRSA5B exceeded the BR Market which returned 8.5% over the past year.
Price Volatility
| MRSA5B volatility | |
|---|---|
| MRSA5B Average Weekly Movement | n/a |
| Transportation Industry Average Movement | 6.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BR Market | 9.1% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: MRSA5B has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MRSA5B's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 6,391 | Guilherme De Mello | www.mrs.com.br |
MRS Logística S.A. is a logistics operator that manages a railway network in Brazil. The company manages a railway network of 1,643 km with a fleet of 20,000 wagons and 650 locomotives in the states of Minas Gerais, Rio de Janeiro, and São Paulo. It transports containers; cement; bauxite; agricultural commodities, such as corn, sugar, soybeans, and soybean meal; and steel products, including iron ore, coal, and coke.
MRS Logística S.A. Fundamentals Summary
| MRSA5B fundamental statistics | |
|---|---|
| Market cap | R$9.87b |
| Earnings (TTM) | R$1.39b |
| Revenue (TTM) | R$7.07b |
7.3x
P/E Ratio1.4x
P/S RatioIs MRSA5B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRSA5B income statement (TTM) | |
|---|---|
| Revenue | R$7.07b |
| Cost of Revenue | R$3.68b |
| Gross Profit | R$3.39b |
| Other Expenses | R$2.00b |
| Earnings | R$1.39b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.11 |
| Gross Margin | 48.00% |
| Net Profit Margin | 19.65% |
| Debt/Equity Ratio | 87.0% |
How did MRSA5B perform over the long term?
See historical performance and comparison